Table 1. Snapshot of Europe Point of Care (PoC) Molecular Diagnostics Market, 2019-2030 18
Table 2. Growth Rate of World Real GDP, 2017-2021 22
Table 3. Main Product Trends and Market Opportunities in Europe Point of Care (PoC) Molecular Diagnostics Market 34
Table 4. Europe Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 43
Table 5. Europe Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 48
Table 6. Europe Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR) by Type, 2019-2030, $ mn 50
Table 7. Europe Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 57
Table 8. Europe Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease by Type, 2019-2030, $ mn 60
Table 9. Europe Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, $ mn 69
Table 10. Europe Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn 78
Table 11. Germany Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 80
Table 12. Germany Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 80
Table 13. Germany Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 80
Table 14. UK Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 82
Table 15. UK Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 82
Table 16. UK Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 82
Table 17. France Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 84
Table 18. France Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 84
Table 19. France Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 84
Table 20. Spain Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 86
Table 21. Spain Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 86
Table 22. Spain Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 86
Table 23. Italy Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 88
Table 24. Italy Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 88
Table 25. Italy Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 88
Table 26. Russia Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 90
Table 27. Russia Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 90
Table 28. Russia Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 90
Table 29. Point of Care (PoC) Molecular Diagnostics Market in Rest of Europe by Country, 2019-2030, $ mn 92
Table 30. Breakdown of Europe Market by Key Vendor, 2019, % 95
Table 31. Abacus Diagnostica Oy: Company Snapshot 98
Table 32. Abacus Diagnostica Oy: Business Segmentation 98
Table 33. Abacus Diagnostica Oy: Product Portfolio 99
Table 34. Abacus Diagnostica Oy: Revenue, 2016-2018, $ mn 99
Table 35. Abacus Diagnostica Oy: Recent Developments 99
Table 36. Risk Evaluation for Investing in Europe Market, 2019-2030 119
Table 37. Critical Success Factors and Key Takeaways 122

LIST OF FIGURE

Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 17
Figure 5. Europe Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn 20
Figure 6. Impact of COVID-19 on Business 24
Figure 7. Primary Drivers and Impact Factors of Europe Point of Care (PoC) Molecular Diagnostics Market 26
Figure 8. World Number of Deaths by Cause in 2017 29
Figure 9. World Number of Deaths from Cancers in 2017 30
Figure 10. Primary Restraints and Impact Factors of Europe Point of Care (PoC) Molecular Diagnostics Market 31
Figure 11. Investment Opportunity Analysis 35
Figure 12. Porters Fiver Forces Analysis of Europe Point of Care (PoC) Molecular Diagnostics Market 38
Figure 13. Breakdown of Europe Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, % of Revenue 43
Figure 14. Europe Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%) 44
Figure 15. Europe Point of Care (PoC) Molecular Diagnostics Market: Kits & Assays, 2019-2030, $ mn 45
Figure 16. Europe Point of Care (PoC) Molecular Diagnostics Market: Analyzers & Instruments, 2019-2030, $ mn 46
Figure 17. Europe Point of Care (PoC) Molecular Diagnostics Market: Software & Services, 2019-2030, $ mn 47
Figure 18. Breakdown of Europe Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, % of Sales Revenue 48
Figure 19. Europe Addressable Market Cap in 2020-2030 by Technology, Value ($ mn) and Share (%) 49
Figure 20. Europe Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR), 2019-2030, $ mn 50
Figure 21. Europe Point of Care (PoC) Molecular Diagnostics Market: Real-Time PCR (rt-PCR), 2019-2030, $ mn 51
Figure 22. Europe Point of Care (PoC) Molecular Diagnostics Market: Digital PCR (d-PCR), 2019-2030, $ mn 52
Figure 23. Europe Point of Care (PoC) Molecular Diagnostics Market: Isothermal Nucleic Acid Amplification Technology (INAAT), 2019-2030, $ mn 53
Figure 24. Europe Point of Care (PoC) Molecular Diagnostics Market: Genetic Sequencing-based Technology, 2019-2030, $ mn 54
Figure 25. Europe Point of Care (PoC) Molecular Diagnostics Market: Microarray-based Technology, 2019-2030, $ mn 55
Figure 26. Europe Point of Care (PoC) Molecular Diagnostics Market: Other Technologies, 2019-2030, $ mn 56
Figure 27. Breakdown of Europe Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, % of Sales Revenue 57
Figure 28. Europe Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 58
Figure 29. Europe Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease, 2019-2030, $ mn 59
Figure 30. Europe Point of Care (PoC) Molecular Diagnostics Market: Respiratory Infections, 2019-2030, $ mn 61
Figure 31. Europe Point of Care (PoC) Molecular Diagnostics Market: Hospital Acquired Infections, 2019-2030, $ mn 62
Figure 32. Europe Point of Care (PoC) Molecular Diagnostics Market: Sexually Transmitted Infections, 2019-2030, $ mn 63
Figure 33. Europe Point of Care (PoC) Molecular Diagnostics Market: Gastrointestinal Infections, 2019-2030, $ mn 64
Figure 34. Europe Point of Care (PoC) Molecular Diagnostics Market: Oncology, 2019-2030, $ mn 65
Figure 35. Europe Point of Care (PoC) Molecular Diagnostics Market: Hepatitis, 2019-2030, $ mn 66
Figure 36. Europe Point of Care (PoC) Molecular Diagnostics Market: Prenatal/Neonatal Testing, 2019-2030, $ mn 67
Figure 37. Europe Point of Care (PoC) Molecular Diagnostics Market: Other Applications, 2019-2030, $ mn 68
Figure 38. Breakdown of Europe Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, % of Revenue 69
Figure 39. Europe Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%) 70
Figure 40. Europe Point of Care (PoC) Molecular Diagnostics Market: Hospitals, 2019-2030, $ mn 71
Figure 41. Europe Point of Care (PoC) Molecular Diagnostics Market: Clinics & Diagnostic Centers, 2019-2030, $ mn 72
Figure 42. Europe Point of Care (PoC) Molecular Diagnostics Market: Research and Academic Institutes, 2019-2030, $ mn 73
Figure 43. Europe Point of Care (PoC) Molecular Diagnostics Market: Other End Users, 2019-2030, $ mn 74
Figure 44. Breakdown of European Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue 77
Figure 45. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 78
Figure 46. Point of Care (PoC) Molecular Diagnostics Market in Germany, 2019-2030, $ mn 79
Figure 47. Point of Care (PoC) Molecular Diagnostics Market in UK, 2019-2030, $ mn 81
Figure 48. Point of Care (PoC) Molecular Diagnostics Market in France, 2019-2030, $ mn 83
Figure 49. Point of Care (PoC) Molecular Diagnostics Market in Spain, 2019-2030, $ mn 85
Figure 50. Point of Care (PoC) Molecular Diagnostics Market in Italy, 2019-2030, $ mn 87
Figure 51. Point of Care (PoC) Molecular Diagnostics Market in Russia, 2019-2030, $ mn 89
Figure 52. Point of Care (PoC) Molecular Diagnostics Market in Rest of Europe, 2019-2030, $ mn 91
Figure 53. Growth Stage of Europe Point of Care (PoC) Molecular Diagnostics Industry over the Forecast Period 93